METHODS OF ASSESSING THE EFFECT OF DRUG-THERAPY ON QUALITY OF LIFE

被引:14
作者
GANZ, PA
机构
[1] Department of Medicine (111B), Veterans Affairs Medical Center, Sepulveda, California, 91343
关键词
D O I
10.2165/00002018-199005040-00001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:233 / 242
页数:10
相关论文
共 51 条
[31]  
Hollandsworth J.G., Evaluating the impact of medical treatment on the quality of life: a five year update, Social Science and Medicine, 26, pp. 425-434, (1988)
[32]  
Johnson J.R., Temple R., Food and drug administration requirements for approval of new anticancer drugs, Cancer Treatment Reports, 69, pp. 1155-1157, (1985)
[33]  
Joyce C.R.B., Quality of life: the state of the art in clinical assessment, In Walker & Rosser (Eds) Quality of life: assessment and application, pp. 169-179, (1988)
[34]  
Kaasa S., Mastekaasa A., Psychosocial well-being of patients with inoperable non-small cell lung cancer. The importance of treatment- and disease-related factors, Acta Oncologica, 27, pp. 829-835, (1988)
[35]  
Kaplan R.M., Anderson J.P., The quality of well-being scale: rationale for a single quality of life index, In Walker & Rosser (Eds) Quality of life: assessment and application, pp. 51-77, (1988)
[36]  
Kaplan R.M., Bush J.W., Health-related quality of life measurement for evaluation research and policy analysis, Health Psychology, 1, pp. 61-80, (1982)
[37]  
Karnofsky D.A., Burchenal J.H., The clinical evaluation of chemotherapeutic agents in cancer, In Macleod (Eds) Evaluation of chemotherapeutic agents, pp. 199-205, (1949)
[38]  
McDowell I., Newell C., Measuring health: a guide to rating scales and questionnaires, (1987)
[39]  
Moinpour C.M., Feigl P., Metch B., Et al., Quality of life end points in cancer clinical trials: review and recommendations, Journal of the National Cancer Institute, 81, pp. 485-495, (1989)
[40]  
Patrick D.L., Deyo R.A., Generic and disease-specific measures in assessing health status and quality of life, Medical Care, 27, (1989)